The effect of Helicobacter pylori eradication on gastro-oesophageal reflux

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 7, 1999, Pages 915-920

  Tefera, S ^a   Hatlebakk, J G ^a   Berstad, A ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH NITRATE; METRONIDAZOLE; OXYTETRACYCLINE; UREA;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CLINICAL ARTICLE; ESOPHAGUS PH; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS;

ADULT; AGED; ANTACIDS; ANTI-BACTERIAL AGENTS; BISMUTH; BREATH TESTS; DRUG THERAPY, COMBINATION; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; METRONIDAZOLE; MIDDLE AGED; OXYTETRACYCLINE; SEVERITY OF ILLNESS INDEX;

EID: 0033042191     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00544.x     Document Type: Article

References (32)

1. Nebel OT, Fornes MF, Castell DO. Symptomatic gastro-oesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 1976; 2: 953-6.
2. Wienbeck M, Rarnert J. Epidemiology of reflux disease and reflux esophagitis. Scand J Gastroenterol 1989; 24(Suppl. 156): 7-13.
3. Castell DO. The Esophagus. 2nd edn. Boston, USA: Little, Brown & Co., 1995.
4. Hogan WJ, Dodds WJ. Gastro-oesophageal reflux disease (reflux oesophagitis). In: Sleisenger MH, Fordtran JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th edn. Philadelphia: W. B. Saunders, 1989: 594-619.
5. Stolte M. Helicobacter pylori gastritis and gastric MALT-lymphoma. Lancet 1992; 339: 745-6.
6. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
7. International Agency for Research on Cancer. Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 177-241.
8. Berstad AE, Hatlebakk JG, Maartmann-Moe H, Berstad A, Brandtzaeg P. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lanzoprazole. Gut 1997; 41: 740-7.
9. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 1018-22.
10. Marshall BJ. Epidemiology of H. pylori in Western countries. In: Hunt RH, Tytgat GNJ, eds. Helicobacter Pylori. Basic Mechanisms to Clinical Cure. Dordrecht: Kluwer Academic Publishers, 1994: 75-84.
11. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the oesophagus and gastric cardia. J Am Med Assoc 1991; 265: 1287-9.
12. Hansson LE, Sparen P, Nyren O. Increasing Incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80: 374-7.
13. Hansen S, Vollset SE, Melby K, et al. Gastric mucosal atrophy is a strong predictor of non-cardia gastric cancer but not of cardia cancer. Gut 1998; 43(Suppl. 2): A63(Abstract).
14. Molloy RM, Sonnenberg A. Relation between gastric cancer and previous peptic ulcer disease. Gut 1997; 40: 247-52.
15. Mihara M, Haruma K, Kamada T, et al. Low prevalence of Helicobacter pylori infection in patients with reflux esophagitis. Gut 1996; 39(Suppl. 2): A94(Abstract).
16. Hackelsberger A, Gunther T, Schultze V, Labenz J, Roessner A, Malfertheiner P. Prevalence and pattern of Helicobacter pylori gastritis in the gastric cardia. Am J Gastroenterol 1997; 92: 2220-4.
17. Sacca N, De Medici A, Rodino S, De Siena M, Giglio A. Reflux oesophagitis: a complication of H. pylori eradication therapy? Endoscopy 1997; 29: 224.
18. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.
19. Hatlebakk JG, Berstad A, Carling L, et al. Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis. Scand J Gastroenterol 1993; 28: 224-8.
20. Berstad A, Olafsson S, Tefera S, et al. A review of five years experience at a university hospital in Norway. J Physiol Pharmacol 1996; 47: 31-49.
21. Tefera S, Berstad A, Bang CJ, et al. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (Metronidazole for eradication, ranitidine for pain). Am J Gastroenterol 1996; 91: 935-41.
22. Berstad K, Wilhelmsen I, Berstad A. Biometric evaluation of gastric urease activity in man. Scand J Gastroenterol 1992; 27: 977-83.
23. Berstad A, Weberg R, Froyshov Larsen I, Hoel B, Hauer-Jensen M. Relationship of hiatus hernia to reflux oesophagitis-a prospective study of coincidence, using endoscopy. Scand J Gastrenterol 1986; 21: 55-8.
24. Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 649-53
25. Carbone F, Neri M, Laterza F, Ricciuti M, Sajterova Z, Cuccurullo F. Twenty-four hour esophageal pH-metry in patient with non-ulcer dyspepsia is unchanged after H. pylori eradication. Gastroenterology 1998; 114: G0342(Abstract).
26. McColl KE, El-Omar E, Gillen D. Interaction between H. pylori infection, gastric acid secretion and anti-secretory therapy. Br Med Bull 1998; 54: 121-38.
27. Murthy UK, Narayana N, Linscheer WG, Nandi J, Oler A. Esophagitis post Helicobacter pylori eradication is associated with persistently low antral D-cell density. Gastroenterology 1998; 114: G0972(Abstract).
28. Wiener GJ, Morgen TM, Copper JB, et al. Ambulatory 24-hour esophageal pH monitoring. Reproducibility and variability of pH parameters. Dig Dis Sci 1988; 33: 1127-33.
29. Genta RM, Lew GM, Graham DY. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod Pathol 1993; 6: 281-9.
30. Solcia E, Villani L, Fiocca R, et al. Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients. Scand J Gastroenterol 1994; 33(Suppl. 201): 28-34.
31. Witteman EM, Marvunac M, Becx MJ, et al. Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori. J Clin Pathol 1995; 48: 250-6.
32. Tucci A, Poli L, Tosetti C, et al. Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol 1998; 93: 1425-31.